Bresta Miranda-Palma

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

A Randomized Trial of Two Irremovable Off-Loading Devices in the Management of Plantar Neuropathic Diabetic Foot Ulcers

Ira A. Katz, Anthony Harlan, Bresta Miranda-Palma et al. · Diabetes Care · 2005 · 240 citations · Full text

Health Professions, Orthopaedic Surgery, Orthopedic Surgery +17

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · Diabetes Care · 2018 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

Chantal Mathieu, Priscilla Hollander, Bresta Miranda-Palma et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 218 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A comparison of the monofilament with other testing modalities for foot ulcer susceptibility

Bresta Miranda-Palma, Jay M. Sosenko, John H. Bowker et al. · Diabetes Research and Clinical Practice · 2005 · 97 citations

Health Professions, Dermatology, Podiatric Medicine +12